Top-Cited Study in Acta Physiologica 2022-2023
/
Knut Dahl-Jørgensen winner of the Knud Lundbæk Award 2024
/
Professor Emeritus Knut Dahl-Jørgensen was honored with the prestigious Knud Lundbæk award from the Scandinavian Society for the Study of Diabetes (SSSD) during its Annual Meeting in Helsinki on 24 May.
Read MoreAdipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus
/
Sørasiater i Norge har høy risiko for type 2 diabetes, men mekanismene bak dette er ukjent. Vi sammenlignet derfor 179 sørasiatiske og 108 nordiske kvinner etter svangerskapsdiabetes.
Read MoreTen years of improving glycemic control in pediatric diabetes care
/
Success in achieving International Society for Pediatric and Adolescent Diabetes’ glycemic targets varies considerably among countries. This paper seeks to evaluate how HbA1c levels and the use of diabetes technology changed in Norway from 2013 to 2022 and how different measures influence glycemic control.
Read MorePublic Defence 3 May – Maryam Saeed
/
Cand.med. Maryam Saeed at Institute of Clinical Medicine will be defending the thesis “Risk of Coronary Heart Disease and End-Stage Renal Disease in Type 1 Diabetes with onset before 15 years of age, 1973 - 2017” for the degree of PhD (Philosophiae Doctor).
Read MoreDigital Technology for Diabetes
/
The use of tissue continuous glucose monitoring (CGM) has increased exponentially the last five years. In the Norwegian diabetes registries 96% of children and 87% of adults with type 1 diabetes in Norway use this technology. The New England Journal ogf Medicine recently had a review article on diabetes technology.
Read MoreResults of the DiViD study
/
Researchers from Oslo Diabetes Research Center today present the results of the DiVID study at the annual meeting of the European Association for the Study of Diabetes in Hamburg. The study was simultaneously published in the high-ranked medical journal Nature Medicine.
Read MorePublic Defence - September 29: Nicolas Fragoso Bargas
/
M.Sc. Nicolas Fragoso Bargas at Institute of Clinical Medicine will be defending the thesis “DNA Methylation and cardiometabolic health: associations with insuline resistance, folate, and physical activity in pregnancy” for the degree of PhD (Philosophiae Doctor).
Read More
"FOLKEMØTE OM DIABETES"
/
Researchers from our center will present news about diabetes and diabetes research to the public at a meeting in Litteraturhuset, Oslo on Tuesday September 26, at 6 p.m.
Read More
Annual summer party
/
On June 14th Oslo Diabetes Research Center celebrated the annual summer party.
Read MoreNOK 16 million awarded to Sindre Lee-Ødegård
/
Sindre Lee-Ødegård has been awarded NOK 16 million in the Excellence Emerging Investigator Grant in endocrinology and metabolism from the Novo Nordisk Foundation.
Read MoreAnnual Centre Seminar, March 23
/
Oslo Diabetes Research Centre’s annual whole-day seminar was held on March 23.
Read More57th Annual Meeting of the European Diabetes Epidemiology Group (EDEG)
/The 57th Annual Meeting will be held 22nd to 25th of April in Soesterberg, the Netherlands.
The abstract deadline will be 15th of January 2023 (no extensions), with confirmation of acceptance before 1st of February 2023. Please visit www.edeg2023.nl to submit your abstract, and for more information about the meeting.
SSSD 2023
/57th Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD2023) in Aarhus
The registration for the 57th Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD2023) in Aarhus, Denmark is now open https://ddeacademy.dk/events/57th-annual-meeting-scandinavian-society-study-diabetes-sssd2023. The Annual Meeting will be held 24-26 May 2023 at the new Steno Diabetes Center Aarhus.
We encourage all researchers/clinicians working within any field of diabetes to participate. Participants are encouraged to submit abstracts, and participation is guaranteed for all who have submitted an abstract. All accepted abstracts will be presented orally with two Outstanding Presentation Awards each of 5000 NOK awarded to the two best presentations.
The program will alternate between invited talks within different areas of diabetes research (complications, epidemiology, appetite regulation, adipose tissue, glucagon, lifestyle interventions), and short oral presentations from participants.
Priority will be given to networking and social events, which will be incorporated throughout the meeting, to facilitate and strengthen collaborative relationships. During the meeting, the annual SSSD research prizes are awarded with presentations from the prize recipients (Knud Lundbæk Award, SSSD Young Investigator Award, Novo Nordisk Foundation Lecture Prize and The Swedish Child Diabetes Foundation Nordic Prize).
Public Defence January 19: Archana Sharma
/Cand.med. Archana Sharma at Institute of Clinical Medicine will be defending the thesis “Glucose metabolism in South Asian and Nordic women with previous gestational diabetes mellitus” for the degree of PhD (Philosophiae Doctor).
Time and place: Jan. 19, 2023 12:15 PM, Store auditorium (Frontbygget), Akershus Universitetssykehus, Sykehusveien 25, Lørenskog
For more information, click Public Defence: Archana Sharma - Institute of Clinical Medicine (uio.no)
Important novel data from the EPIPREG study presented in the prestigious journal Diabetes
/With data from the EPIPREG sample, we identified six cross-ancestry CpG sites related to insulin resistance in pregnancy, whereof five were replicated in independent studies. From methylation quantitative trait loci analysis, we identified gene variants related to all five replicated cross-ancestry CpG sites, which were associated with several cardiometabolic phenotypes. Mediation analyses suggested that the gene variants regulate insulin resistance through DNA methylation.
DIABETES, December 19th 2022, online ahead of print: Click here
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
/Using data from 24 population-based data sources from Europe, Asia, North America, and Oceania, we estimated the lifetime risk of type 2 diabetes, life expectancy in people with and without type 2 diabetes, and years of life lost to type 2 diabetes. With the incidence of type 2 diabetes declining in the high-income setting, there has been a corresponding decrease in lifetime risk in many high-income jurisdictions.
However, the burden of diabetes remains high. This substantial individual burden should be considered in future public health strategy and emphasised in patient counselling to improve health outcomes for people with type 2 diabetes.
THE LANCET Diabetes and Endocrinology VOLUME 10, ISSUE 11, NOVEMBER 01, 2022
Sindre Lee Ødegård (post-doc) får stipend fra Norsk endokrinologisk Forening
/Astra-Zeneca og Norsk Endokrinologisk Forening har lyst ut forskningsmidler ment for å stimulere klinisk forskning i Norge innen terapiområdet diabetes.
Post-doc Sindre Lee-Ødegård ved UiO har søkt om midler for å gjennomføre proteom-kartlegging hos 60 personer med risiko for type 2 diabetes (kvinner av sør-asiatisk eller nordisk opprinnelse med tidligere svangerskapsdiabetes) med mål om å forbedre patofysiologisk forståelse, risiko-stratifisering og identifikasjon av mulige nye behandlingsmål/intervensjonsmuligheter. Prosjektet fremstår å være gjennomførbart, hvor søker kommer fra et faglig sterkt miljø og har en solid publikasjonsliste.
Tematisk tilhører prosjektet et spennende felt innen presisjonsmedisin, med potensiale for nye funn som på sikt kan ha klinisk nytte.
